查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463813

全球疤痕治疗市场：市场规模和份额分析（按治疗类型、疤痕类型和最终用户）、行业需求预测（截至2030年）

Scar Treatment Market Size and Share Analysis by Treatment Type, Scar Type, End User - Global Industry Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 310 Pages | 商品交期: 2-3个工作天内

价格
简介目录

主要亮点

2023年，全球疤痕治疗市场将达238亿美元，2030年将达528亿美元，复合年增长率超过12.0%。

人们对疤痕管理的认识不断提高，大众对获得完美肌肤的兴趣日益浓厚，对整容手术的需求迅速增加，以及医疗技术的进步正在推动该行业的扩张。

如今已有改良的美容手段，包括雷射、化学换肤、微晶磨皮术和磨皮术。 这些进步使得为改善美观提供更有效的选择成为可能。

市场洞察

到 2023 年，北美将成为最大的地区，份额约为 37.8%。

北美地区可支配收入较高，导致个人护理产品成本较高，是该地区产业的主要影响因素。

到 2023 年，美国将成为北美工业的最大贡献者，并且在这十年中可能会以更快的复合年增长率取得进步。

雷射类别预计将呈现十年来最高成长率，达到 12.7%。 这是因为雷射治疗比目前可用的治疗更先进。

到 2023 年，萎缩性疤痕和痤疮疤痕将以 40.1% 的份额主导该行业，并且在这十年中仍将是最大的。

疤痕疙瘩和肥厚疤痕类别预计在未来几年将以最快的复合年增长率增长。 这是由于手术数量不断增加以及烧伤和创伤的发生率增加。

本报告分析了全球疤痕治疗市场，包括市场的基本结构和最新情况、主要促进和抑制因素以及全球、按地区和主要国家的市场规模前景（以货币形式计算） （2017-2030），按治疗类型、疤痕类型和最终用户划分的详细趋势、当前市场竞争状况以及主要公司概况。

目录

第1章研究范围

第2章研究方法

第 3 章执行摘要

第 4 章市场指标

第5章产业展望

  • 市场动态
    • 趋势
    • 促进因素
    • 抑制因素/挑战
    • 促进/抑制因子影响分析
  • 新型冠状病毒感染 (COVID-19) 的影响
  • 波特五力分析

第6章世界市场

  • 摘要
  • 市场收入：依治疗类型分类（2017-2030 年）
    • 局部治疗市场收入：按类型划分（2017-2030 年）
    • 表面处理市场收入：按类型划分（2017-2030 年）
    • 雷射治疗市场收入：按类型划分（2017-2030 年）
    • 注射疗法市场收入：按类型划分（2017-2030 年）
  • 市场收入：依疤痕类型分类（2017-2030 年）
  • 市场收入：以最终用户划分（2017-2030 年）
  • 市场收入：按地区划分（2017-2030 年）

第7章北美市场

  • 摘要
  • 市场收入：依治疗类型分类（2017-2030 年）
    • 局部治疗市场收入：按类型划分（2017-2030 年）
    • 表面处理市场收入：按类型划分（2017-2030 年）
    • 雷射治疗市场收入：按类型划分（2017-2030 年）
    • 注射疗法市场收入：按类型划分（2017-2030 年）
  • 市场收入：依疤痕类型分类（2017-2030 年）
  • 市场收入：以最终用户划分（2017-2030 年）
  • 市场收入：依国家/地区划分（2017-2030 年）

第8章欧洲市场

第9章亚太市场

第10章拉丁美洲市场

第11章中东及非洲市场

第12章美国市场

  • 摘要
  • 市场收入：依治疗类型分类（2017-2030 年）
    • 局部治疗市场收入：按类型划分（2017-2030 年）
    • 表面处理市场收入：按类型划分（2017-2030 年）
    • 雷射治疗市场收入：按类型划分（2017-2030 年）
    • 注射疗法市场收入：按类型划分（2017-2030 年）
  • 市场收入：依疤痕类型分类（2017-2030 年）
  • 市场收入：以最终用户划分（2017-2030 年）

第13章加拿大市场

第14章德国市场

第15章法国市场

第16章英国市场

第17章义大利市场

第18章西班牙市场

第19章日本市场

第20章中国市场

第21章印度市场

第22章澳洲市场

第23章韩国市场

第24章巴西市场

第25章墨西哥市场

第26章沙乌地阿拉伯市场

第27章南非市场

第 28 章阿联酋 (UAE) 市场

第29章竞争态势

  • 市场参与者及其产品列表
  • 主要公司的竞争基准
  • 各大公司的产品基准
  • 近期策略发展状况

第30章公司简介

  • Avita Medical Inc.
  • Revitol Corporation
  • Sonoma Pharmaceuticals Inc.
  • Molnlycke Health Care AB
  • CCA Industries Inc.
  • Sisram Medical Ltd.
  • Biodermis
  • Candela Corporation
  • Smith & Nephew plc
  • Scarguard Labs LLC

第31章 附录

简介目录
Product Code: 10180

Key Highlights

The scar treatment market generated a value of USD 23.8 billion in 2023, which will rise to USD 52.8 billion, advancing at over 12.0% CAGR, by 2030.

The rising consciousness regarding scar management, increasing interest of people in having flawless skin, surging need for cosmetic procedures, and evolving medical technology are aiding the industry expansion.

Individuals with long-term disfigurement due to burns, accidents, surgery, or other reasons are searching for effective means to improve their appearance.

The development of different therapies that decrease the scar's visibility and improve the overall skin texture has been enabled by the improvements in medical technology.

The improved cosmetic measures now accessible comprise lasers, chemical peels, microdermabrasion, and dermabrasion.

These advancements have made it possible to offer less intrusive as well as more effective choices to individuals for improving their aesthetics.

There has been an increasing acceptance of scar revision solutions because of the rising consciousness about the different options of treatment accessible.

The public has profited from the information provided by plastic surgeons, skincare experts, and dermatologists about the benefits of under-trial and current skin treatments.

With the arrival of elective surgeries and medical tourism, the count of surgical measures is increasing at a significant pace. This means that now, more potential patients are searching for post-surgery scar treatment.

Market Insights

North America was the largest contributor to the industry in 2023, with a share of approximately 37.8%.

The high disposable salary in North America, which results in a rise in the expenses on personal care products, is a major contributor to the dominance of the regional industry.

In 2023, the U.S. was the largest contributor to the industry in North America, and it is likely to advance at a faster compound annual growth rate during this decade.

The laser category will advance at the highest rate, of 12.7%, during this decade. This will be because laser treatments are more advanced than the currently accessible topical therapies.

Atrophic and acne scars accounted for the largest share of the industry in 2023, with a 40.1% share, and it will remain the largest throughout this decade.

Acne is among of the most common dermatological conditions globally, particularly among adolescents.

Acne occurs because of the clogging of the hair follicles in the skin with sebum, dirt, oil, dead skin cells, and various other impurities, which leads to lesions formation.

Approximately 9.4% of the global population suffers from acne, making it the 8th most prevalent illness in the world.

The keloid and hypertrophic scar category will propel at the fastest CAGR in the years to come. This will be because of the rising volume of surgeries, coupled with the incidence of burn injuries as well as traumatic wounds.

The scar treatment industry is moderately fragmented with the existence of some local players. Players in this industry are trying to enhance their presence by implementing strategies like mergers & acquisitions, partnerships, and investments.

The industry players are also concentrating on sustaining competitive pricing and investing in developing greater and more effective products.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by treatment type
    • 1.4.2. Market size breakdown, by scar type
    • 1.4.3. Market size breakdown, by end user
    • 1.4.4. Market size breakdown, by region
    • 1.4.5. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Revenue, by Treatment Type (2017-2030)
    • 6.2.1. Topical market revenue, by type (2017-2030)
    • 6.2.2. Surface market revenue, by type (2017-2030)
    • 6.2.3. Laser market revenue, by type (2017-2030)
    • 6.2.4. Injectable market revenue, by type (2017-2030)
  • 6.3. Market Revenue, by Scar Type (2017-2030)
  • 6.4. Market Revenue, by End User (2017-2030)
  • 6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Revenue, by Treatment Type (2017-2030)
    • 7.2.1. Topical market revenue, by type (2017-2030)
    • 7.2.2. Surface market revenue, by type (2017-2030)
    • 7.2.3. Laser market revenue, by type (2017-2030)
    • 7.2.4. Injectable market revenue, by type (2017-2030)
  • 7.3. Market Revenue, by Scar Type (2017-2030)
  • 7.4. Market Revenue, by End User (2017-2030)
  • 7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Revenue, by Treatment Type (2017-2030)
    • 8.2.1. Topical market revenue, by type (2017-2030)
    • 8.2.2. Surface market revenue, by type (2017-2030)
    • 8.2.3. Laser market revenue, by type (2017-2030)
    • 8.2.4. Injectable market revenue, by type (2017-2030)
  • 8.3. Market Revenue, by Scar Type (2017-2030)
  • 8.4. Market Revenue, by End User (2017-2030)
  • 8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Revenue, by Treatment Type (2017-2030)
    • 9.2.1. Topical market revenue, by type (2017-2030)
    • 9.2.2. Surface market revenue, by type (2017-2030)
    • 9.2.3. Laser market revenue, by type (2017-2030)
    • 9.2.4. Injectable market revenue, by type (2017-2030)
  • 9.3. Market Revenue, by Scar Type (2017-2030)
  • 9.4. Market Revenue, by End User (2017-2030)
  • 9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Revenue, by Treatment Type (2017-2030)
    • 10.2.1. Topical market revenue, by type (2017-2030)
    • 10.2.2. Surface market revenue, by type (2017-2030)
    • 10.2.3. Laser market revenue, by type (2017-2030)
    • 10.2.4. Injectable market revenue, by type (2017-2030)
  • 10.3. Market Revenue, by Scar Type (2017-2030)
  • 10.4. Market Revenue, by End User (2017-2030)
  • 10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Revenue, by Treatment Type (2017-2030)
    • 11.2.1. Topical market revenue, by type (2017-2030)
    • 11.2.2. Surface market revenue, by type (2017-2030)
    • 11.2.3. Laser market revenue, by type (2017-2030)
    • 11.2.4. Injectable market revenue, by type (2017-2030)
  • 11.3. Market Revenue, by Scar Type (2017-2030)
  • 11.4. Market Revenue, by End User (2017-2030)
  • 11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Revenue, by Treatment Type (2017-2030)
    • 12.2.1. Topical market revenue, by type (2017-2030)
    • 12.2.2. Surface market revenue, by type (2017-2030)
    • 12.2.3. Laser market revenue, by type (2017-2030)
    • 12.2.4. Injectable market revenue, by type (2017-2030)
  • 12.3. Market Revenue, by Scar Type (2017-2030)
  • 12.4. Market Revenue, by End User (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Revenue, by Treatment Type (2017-2030)
    • 13.2.1. Topical market revenue, by type (2017-2030)
    • 13.2.2. Surface market revenue, by type (2017-2030)
    • 13.2.3. Laser market revenue, by type (2017-2030)
    • 13.2.4. Injectable market revenue, by type (2017-2030)
  • 13.3. Market Revenue, by Scar Type (2017-2030)
  • 13.4. Market Revenue, by End User (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Revenue, by Treatment Type (2017-2030)
    • 14.2.1. Topical market revenue, by type (2017-2030)
    • 14.2.2. Surface market revenue, by type (2017-2030)
    • 14.2.3. Laser market revenue, by type (2017-2030)
    • 14.2.4. Injectable market revenue, by type (2017-2030)
  • 14.3. Market Revenue, by Scar Type (2017-2030)
  • 14.4. Market Revenue, by End User (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Revenue, by Treatment Type (2017-2030)
    • 15.2.1. Topical market revenue, by type (2017-2030)
    • 15.2.2. Surface market revenue, by type (2017-2030)
    • 15.2.3. Laser market revenue, by type (2017-2030)
    • 15.2.4. Injectable market revenue, by type (2017-2030)
  • 15.3. Market Revenue, by Scar Type (2017-2030)
  • 15.4. Market Revenue, by End User (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Revenue, by Treatment Type (2017-2030)
    • 16.2.1. Topical market revenue, by type (2017-2030)
    • 16.2.2. Surface market revenue, by type (2017-2030)
    • 16.2.3. Laser market revenue, by type (2017-2030)
    • 16.2.4. Injectable market revenue, by type (2017-2030)
  • 16.3. Market Revenue, by Scar Type (2017-2030)
  • 16.4. Market Revenue, by End User (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Revenue, by Treatment Type (2017-2030)
    • 17.2.1. Topical market revenue, by type (2017-2030)
    • 17.2.2. Surface market revenue, by type (2017-2030)
    • 17.2.3. Laser market revenue, by type (2017-2030)
    • 17.2.4. Injectable market revenue, by type (2017-2030)
  • 17.3. Market Revenue, by Scar Type (2017-2030)
  • 17.4. Market Revenue, by End User (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Revenue, by Treatment Type (2017-2030)
    • 18.2.1. Topical market revenue, by type (2017-2030)
    • 18.2.2. Surface market revenue, by type (2017-2030)
    • 18.2.3. Laser market revenue, by type (2017-2030)
    • 18.2.4. Injectable market revenue, by type (2017-2030)
  • 18.3. Market Revenue, by Scar Type (2017-2030)
  • 18.4. Market Revenue, by End User (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Revenue, by Treatment Type (2017-2030)
    • 19.2.1. Topical market revenue, by type (2017-2030)
    • 19.2.2. Surface market revenue, by type (2017-2030)
    • 19.2.3. Laser market revenue, by type (2017-2030)
    • 19.2.4. Injectable market revenue, by type (2017-2030)
  • 19.3. Market Revenue, by Scar Type (2017-2030)
  • 19.4. Market Revenue, by End User (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Revenue, by Treatment Type (2017-2030)
    • 20.2.1. Topical market revenue, by type (2017-2030)
    • 20.2.2. Surface market revenue, by type (2017-2030)
    • 20.2.3. Laser market revenue, by type (2017-2030)
    • 20.2.4. Injectable market revenue, by type (2017-2030)
  • 20.3. Market Revenue, by Scar Type (2017-2030)
  • 20.4. Market Revenue, by End User (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Revenue, by Treatment Type (2017-2030)
    • 21.2.1. Topical market revenue, by type (2017-2030)
    • 21.2.2. Surface market revenue, by type (2017-2030)
    • 21.2.3. Laser market revenue, by type (2017-2030)
    • 21.2.4. Injectable market revenue, by type (2017-2030)
  • 21.3. Market Revenue, by Scar Type (2017-2030)
  • 21.4. Market Revenue, by End User (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Revenue, by Treatment Type (2017-2030)
    • 22.2.1. Topical market revenue, by type (2017-2030)
    • 22.2.2. Surface market revenue, by type (2017-2030)
    • 22.2.3. Laser market revenue, by type (2017-2030)
    • 22.2.4. Injectable market revenue, by type (2017-2030)
  • 22.3. Market Revenue, by Scar Type (2017-2030)
  • 22.4. Market Revenue, by End User (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Revenue, by Treatment Type (2017-2030)
    • 23.2.1. Topical market revenue, by type (2017-2030)
    • 23.2.2. Surface market revenue, by type (2017-2030)
    • 23.2.3. Laser market revenue, by type (2017-2030)
    • 23.2.4. Injectable market revenue, by type (2017-2030)
  • 23.3. Market Revenue, by Scar Type (2017-2030)
  • 23.4. Market Revenue, by End User (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Revenue, by Treatment Type (2017-2030)
    • 24.2.1. Topical market revenue, by type (2017-2030)
    • 24.2.2. Surface market revenue, by type (2017-2030)
    • 24.2.3. Laser market revenue, by type (2017-2030)
    • 24.2.4. Injectable market revenue, by type (2017-2030)
  • 24.3. Market Revenue, by Scar Type (2017-2030)
  • 24.4. Market Revenue, by End User (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Revenue, by Treatment Type (2017-2030)
    • 25.2.1. Topical market revenue, by type (2017-2030)
    • 25.2.2. Surface market revenue, by type (2017-2030)
    • 25.2.3. Laser market revenue, by type (2017-2030)
    • 25.2.4. Injectable market revenue, by type (2017-2030)
  • 25.3. Market Revenue, by Scar Type (2017-2030)
  • 25.4. Market Revenue, by End User (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Revenue, by Treatment Type (2017-2030)
    • 26.2.1. Topical market revenue, by type (2017-2030)
    • 26.2.2. Surface market revenue, by type (2017-2030)
    • 26.2.3. Laser market revenue, by type (2017-2030)
    • 26.2.4. Injectable market revenue, by type (2017-2030)
  • 26.3. Market Revenue, by Scar Type (2017-2030)
  • 26.4. Market Revenue, by End User (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Revenue, by Treatment Type (2017-2030)
    • 27.2.1. Topical market revenue, by type (2017-2030)
    • 27.2.2. Surface market revenue, by type (2017-2030)
    • 27.2.3. Laser market revenue, by type (2017-2030)
    • 27.2.4. Injectable market revenue, by type (2017-2030)
  • 27.3. Market Revenue, by Scar Type (2017-2030)
  • 27.4. Market Revenue, by End User (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Revenue, by Treatment Type (2017-2030)
    • 28.2.1. Topical market revenue, by type (2017-2030)
    • 28.2.2. Surface market revenue, by type (2017-2030)
    • 28.2.3. Laser market revenue, by type (2017-2030)
    • 28.2.4. Injectable market revenue, by type (2017-2030)
  • 28.3. Market Revenue, by Scar Type (2017-2030)
  • 28.4. Market Revenue, by End User (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Avita Medical Inc.
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Revitol Corporation
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Sonoma Pharmaceuticals Inc.
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Molnlycke Health Care AB
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. CCA Industries Inc.
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Sisram Medical Ltd.
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Biodermis
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Candela Corporation
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Smith & Nephew plc
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. Scarguard Labs LLC
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports